Abstract
There have been 18 breakthrough cases of mild varicella in 240 luekemic recipients of live attenuated OKA varicella vaccine in studies over the past 4 years. To determine why most vaccinees have been protected from illness after exposure but some have not, we analyzed immune responses to varicella-zoster virus (VZV) in: 1)6 normals, years after natural infection, 2) 41 vaccinees before immunization, 3) 23 vaccinees protected from varicella after household exposure, & 4)18 vaccinees who developed varicella. VZV antibody was measured by fluorescent antibody to membrane antigen (FAMA) & cellular immunity (CMI) by lymphocyte stimulation to VZV antigen, expressed as a stimulation index (SI).
These data indicate that in general, the higher the VZ antibody titer the better the protection against varicella. Vaccinees with a breakthrough illness, however, have partial immunity that appears to protect them from severe disease.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gershon, A., Steinberg, S. 1098 DETERMINANTS OF IMMUNITY TO VARICELLA. Pediatr Res 19, 293 (1985). https://doi.org/10.1203/00006450-198504000-01128
Issue Date:
DOI: https://doi.org/10.1203/00006450-198504000-01128